SI2691110T1 - Sredstva in postopki za aktivno celično imunoterapijo raka z uporabo tumorskih celic, pokončanih z visokim hidrostatičnim tlakom, in dendritskih celic - Google Patents
Sredstva in postopki za aktivno celično imunoterapijo raka z uporabo tumorskih celic, pokončanih z visokim hidrostatičnim tlakom, in dendritskih celicInfo
- Publication number
- SI2691110T1 SI2691110T1 SI201230120T SI201230120T SI2691110T1 SI 2691110 T1 SI2691110 T1 SI 2691110T1 SI 201230120 T SI201230120 T SI 201230120T SI 201230120 T SI201230120 T SI 201230120T SI 2691110 T1 SI2691110 T1 SI 2691110T1
- Authority
- SI
- Slovenia
- Prior art keywords
- cancer
- methods
- hydrostatic pressure
- cellular immunotherapy
- high hydrostatic
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 230000001413 cellular effect Effects 0.000 title 1
- 210000004443 dendritic cell Anatomy 0.000 title 1
- 238000009169 immunotherapy Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000009931 pascalization Methods 0.000 title 1
- 210000004881 tumor cell Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4615—Dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4622—Antigen presenting cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/464493—Prostate associated antigens e.g. Prostate stem cell antigen [PSCA]; Prostate carcinoma tumor antigen [PCTA]; Prostatic acid phosphatase [PAP]; Prostate-specific G-protein-coupled receptor [PSGR]
- A61K39/464494—Prostate specific antigen [PSA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5152—Tumor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
- A61K2239/58—Prostate
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Developmental Biology & Embryology (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161504387P | 2011-07-05 | 2011-07-05 | |
| EP11172622A EP2543386A1 (en) | 2011-07-05 | 2011-07-05 | Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure |
| PCT/EP2012/062950 WO2013004708A1 (en) | 2011-07-05 | 2012-07-04 | Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure and dendritic cells |
| EP12734884.5A EP2691110B1 (en) | 2011-07-05 | 2012-07-04 | Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure and dendritic cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2691110T1 true SI2691110T1 (sl) | 2015-01-30 |
Family
ID=44359435
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201230120T SI2691110T1 (sl) | 2011-07-05 | 2012-07-04 | Sredstva in postopki za aktivno celično imunoterapijo raka z uporabo tumorskih celic, pokončanih z visokim hidrostatičnim tlakom, in dendritskih celic |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20140086957A1 (sl) |
| EP (2) | EP2543386A1 (sl) |
| JP (1) | JP5986196B2 (sl) |
| KR (1) | KR102035873B1 (sl) |
| CN (3) | CN109125347A (sl) |
| AU (2) | AU2012280322B2 (sl) |
| BR (2) | BR112013031084B1 (sl) |
| CA (1) | CA2833946A1 (sl) |
| DK (1) | DK2691110T3 (sl) |
| EA (1) | EA030061B1 (sl) |
| ES (1) | ES2525759T3 (sl) |
| PL (1) | PL2691110T3 (sl) |
| PT (1) | PT2691110E (sl) |
| RS (1) | RS53713B1 (sl) |
| RU (1) | RU2012127685A (sl) |
| SG (1) | SG194201A1 (sl) |
| SI (1) | SI2691110T1 (sl) |
| SM (1) | SMT201400188B (sl) |
| UA (1) | UA111738C2 (sl) |
| WO (1) | WO2013004708A1 (sl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130011438A1 (en) | 2011-07-05 | 2013-01-10 | SOTIO a.s. | Means And Methods For Active Cellular Immunotherapy Of Cancer By Using Tumor Cells Killed By High Hydrostatic Pressure and Dendritic Cells |
| US9562219B2 (en) | 2013-12-27 | 2017-02-07 | SOTIO a.s. | Cryopreservation of apoptotic cancer cells for use in immunotherapy against cancer |
| CN104258384B (zh) * | 2014-09-29 | 2017-05-03 | 北京时合生物科技有限公司 | 一种基于树突状细胞的特异性肿瘤疫苗的制备方法 |
| CN107921063A (zh) * | 2015-07-02 | 2018-04-17 | 普莱瓦克斯免疫肿瘤学公司 | 用于采用登革病毒与树突细胞的联合疗法的组合物及方法 |
| CN106244543A (zh) * | 2016-07-29 | 2016-12-21 | 北京时合生物科技有限公司 | 一种pbmc体外诱导分化成为树突状细胞的方法 |
| JP2020507616A (ja) * | 2017-02-17 | 2020-03-12 | アイビタ バイオメディカル インコーポレイテッド | 改変された腫瘍細胞および改変された樹状細胞を使用して、腫瘍免疫原性を増強する方法および自己癌免疫療法製品の組成物 |
| CN109810946B (zh) * | 2017-11-21 | 2023-11-21 | 中国科学院上海药物研究所 | 天花粉蛋白用于致敏和/激活树突状细胞中的应用 |
| KR20200116112A (ko) * | 2018-01-25 | 2020-10-08 | 소티오 에이.에스. | 화학요법에 순차적인 수지상 세포 백신접종 |
| CA3087823A1 (en) | 2018-01-25 | 2019-08-01 | SOTIO a.s. | Dendritic cell vaccination in parallel to chemotherapy |
| WO2020187975A1 (en) | 2019-03-19 | 2020-09-24 | SOTIO a.s. | Patient selection for treatment with dendritic cell vaccination |
| JP7340240B2 (ja) * | 2019-08-26 | 2023-09-07 | 学校法人関西医科大学 | 細胞又は組織にアポトーシスを誘導する方法 |
| WO2022171792A1 (en) | 2021-02-12 | 2022-08-18 | Sctbio A.S. | Patient selection for treatment with dendritic cell vaccination |
| AU2022325498A1 (en) | 2021-08-13 | 2024-02-01 | Cytune Pharma | Il-2/il-15rbetagamma agonist combination with antibody-drug conjugates for treating cancer |
| CN114807229A (zh) * | 2022-05-27 | 2022-07-29 | 中国科学院长春应用化学研究所 | 细胞膜、纳米疫苗及其制备方法和应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6602709B1 (en) * | 1998-02-20 | 2003-08-05 | The Rockefeller University | Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells |
| US20060216269A1 (en) * | 2004-09-17 | 2006-09-28 | Kenichiro Hasumi | Dendritic cell tumor injection (DCTI) therapy |
| WO2006047515A2 (en) | 2004-10-25 | 2006-05-04 | Baylor Research Institute | Dendritic cells loaded with heat shocked melanoma cell bodies |
| WO2006095330A2 (en) * | 2005-03-10 | 2006-09-14 | Yeda Research And Development Co. Ltd. | Methods and immunogenic cell preparations for treating antigen-associated diseases |
| KR100647847B1 (ko) * | 2005-05-27 | 2006-11-23 | 크레아젠 주식회사 | 인간 전립선암 동물모델 및 이를 이용한 수지상세포-유래전립선암 면역치료제의 예방 및 치료 효능을 분석하는 방법 |
-
2011
- 2011-07-05 EP EP11172622A patent/EP2543386A1/en not_active Withdrawn
-
2012
- 2012-04-07 UA UAA201312611A patent/UA111738C2/uk unknown
- 2012-07-03 RU RU2012127685/15A patent/RU2012127685A/ru unknown
- 2012-07-04 CN CN201810985605.9A patent/CN109125347A/zh active Pending
- 2012-07-04 SI SI201230120T patent/SI2691110T1/sl unknown
- 2012-07-04 JP JP2014517778A patent/JP5986196B2/ja active Active
- 2012-07-04 BR BR112013031084-7A patent/BR112013031084B1/pt active IP Right Grant
- 2012-07-04 ES ES12734884.5T patent/ES2525759T3/es active Active
- 2012-07-04 CA CA2833946A patent/CA2833946A1/en active Pending
- 2012-07-04 CN CN201280032974.7A patent/CN103648524B/zh active Active
- 2012-07-04 EP EP12734884.5A patent/EP2691110B1/en active Active
- 2012-07-04 KR KR1020137032259A patent/KR102035873B1/ko active IP Right Grant
- 2012-07-04 WO PCT/EP2012/062950 patent/WO2013004708A1/en active Application Filing
- 2012-07-04 CN CN2012102924999A patent/CN102861103A/zh active Pending
- 2012-07-04 US US14/113,337 patent/US20140086957A1/en not_active Abandoned
- 2012-07-04 SG SG2013077128A patent/SG194201A1/en unknown
- 2012-07-04 PL PL12734884T patent/PL2691110T3/pl unknown
- 2012-07-04 RS RS20140685A patent/RS53713B1/en unknown
- 2012-07-04 BR BR122019026627-1A patent/BR122019026627B1/pt active IP Right Grant
- 2012-07-04 DK DK12734884.5T patent/DK2691110T3/en active
- 2012-07-04 AU AU2012280322A patent/AU2012280322B2/en active Active
- 2012-07-04 PT PT127348845T patent/PT2691110E/pt unknown
- 2012-07-04 EA EA201301089A patent/EA030061B1/ru unknown
-
2014
- 2014-12-17 SM SM201400188T patent/SMT201400188B/xx unknown
-
2016
- 2016-09-28 AU AU2016234915A patent/AU2016234915B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EA030061B1 (ru) | 2018-06-29 |
| BR122019026627B1 (pt) | 2021-01-12 |
| PT2691110E (pt) | 2014-12-22 |
| SMT201400188B (it) | 2015-03-05 |
| ES2525759T3 (es) | 2014-12-30 |
| NZ618000A (en) | 2014-12-24 |
| US20140086957A1 (en) | 2014-03-27 |
| KR102035873B1 (ko) | 2019-10-23 |
| KR20140040734A (ko) | 2014-04-03 |
| CN103648524B (zh) | 2016-08-17 |
| EP2691110B1 (en) | 2014-10-29 |
| BR112013031084A2 (pt) | 2016-11-29 |
| CA2833946A1 (en) | 2013-01-10 |
| EA201301089A1 (ru) | 2014-05-30 |
| EP2691110A1 (en) | 2014-02-05 |
| WO2013004708A1 (en) | 2013-01-10 |
| PL2691110T3 (pl) | 2015-03-31 |
| DK2691110T3 (en) | 2014-11-17 |
| EP2543386A1 (en) | 2013-01-09 |
| BR112013031084B1 (pt) | 2021-01-12 |
| JP5986196B2 (ja) | 2016-09-06 |
| CN109125347A (zh) | 2019-01-04 |
| CN103648524A (zh) | 2014-03-19 |
| CN102861103A (zh) | 2013-01-09 |
| RS53713B1 (en) | 2015-04-30 |
| AU2016234915B2 (en) | 2017-08-31 |
| RU2012127685A (ru) | 2014-01-20 |
| UA111738C2 (uk) | 2016-06-10 |
| JP2014520780A (ja) | 2014-08-25 |
| AU2012280322B2 (en) | 2016-07-21 |
| AU2016234915A1 (en) | 2016-10-20 |
| SG194201A1 (en) | 2013-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI2691110T1 (sl) | Sredstva in postopki za aktivno celično imunoterapijo raka z uporabo tumorskih celic, pokončanih z visokim hidrostatičnim tlakom, in dendritskih celic | |
| IL288241A (en) | Improved cell culture methods for stress cell therapy | |
| IL271005A (en) | Improved cell culture methods for stress cell therapy | |
| IL247781A0 (en) | Means and methods for active cellular immunotherapy of cancer using tumor cells killed by high hydrostatic pressure and dendritic cells | |
| IL231171A0 (en) | RNA-derived t cells for cancer treatment | |
| BR112013014076A2 (pt) | métodos de direcionamento metabólico de células de câncer usando quimio- e imunotherapia para tratamento de câncer | |
| HK1254859A1 (zh) | 治療乳腺癌的方法 | |
| EP2614143A4 (en) | CANCER IMMUNOTHERAPY USING GENETICALLY MODIFIED, SPECIFIC GD2 T LYMPHOCYTES | |
| EP2760452A4 (en) | METHODS OF TREATING CANCER | |
| IL232890A0 (en) | Immunogenic therapy for cancer | |
| GB201100180D0 (en) | Tumour cell and tissue culture | |
| HK1202796A1 (en) | Delivery system for specifically targeting cancer cells and method of use thereof | |
| FI2547205T3 (fi) | Uusia menetelmiä syövän kantasolujen kohdentamiseksi | |
| EP2736527A4 (en) | DENDRITIC CELL VACCINOTHERAPY (CD) FOR PANCREATIC CANCER | |
| EP2780033A4 (en) | METHODS OF TREATING CANCER | |
| HK1202070A1 (en) | Vaccine for tumor immunotherapy | |
| EP2968406A4 (en) | AUTOLOGOUS TUMOR LYSAT-FILLED DENDRITIC CELL VACCINE FOR THE TREATMENT OF LIVER CANCER | |
| IL230479A0 (en) | A method of treating cancer through the combined use of drugs | |
| WO2011109677A3 (en) | Methods of increasing macropinocytosis in cancer cells | |
| WO2012138566A9 (en) | Genetic determinants of prostate and breast cancer risk | |
| EP2531211A4 (en) | METHOD FOR THE SENSITIZATION OF CELLS TO TREATMENT AGAINST CANCER | |
| EP2750691A4 (en) | SRPX IN THE TREATMENT OF CANCER | |
| AU2012905667A0 (en) | Vaccines for treatment of cancer |